Who Paid My Doc
REDEFINE-HF Study #22438
Research payments
$1,386,105
Through program year 2025, $1,386,105 in research payments was reported against REDEFINE-HF Study #22438, across 399 payments, paid by Bayer HealthCare Pharmaceuticals Inc..
- Paid by
- Bayer HealthCare Pharmaceuticals Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
1 row| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $1,386,105 | 399 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Kaushik Jain Huntsville, AL Named on 32 payments
- Rita Jermyn Roslyn, NY Named on 30 payments
- Jana Svetlichnaya San Francisco, CA Named on 22 payments
- Mikhail Kosiborod Kansas City, MO Named on 22 payments
- Andrew Sauer Lees Summit, MO Named on 20 payments
- Matthew Lander Pittsburgh, PA Named on 13 payments
- David Kraus Saint Louis, MO Named on 13 payments
- Farhad Rafii West Hills, CA Named on 12 payments
- Sandra Chaparro Miami, FL Named on 12 payments
- David Moll Baton Rouge, LA Named on 11 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.